Medicine and Dentistry
Patient
100%
Breast Cancer
59%
Biological Marker
57%
Neoplasm
52%
Assay
45%
Development
38%
Malignant Neoplasm
38%
Therapeutic Procedure
36%
Inpatient
34%
DNA Damage
31%
Formaldehyde
30%
Paraffin
30%
BRCA1
29%
Ovarian Cancer
29%
Survival
28%
Tissues
27%
Combination Therapy
27%
Krukenberg Tumor
27%
Colorectal Cancer
26%
Prostate Cancer
26%
Chemotherapy
24%
Gene
22%
Diseases
22%
Colon Cancer
21%
Immune Response
21%
Triple Negative Breast Cancer
20%
Neoadjuvant Chemotherapy
19%
Recurrent Disease
19%
Esophageal Adenocarcinoma
16%
Surgery
15%
Microarray
15%
Cells
15%
Prognosis
14%
Hazard Ratio
14%
PARP Inhibitor
13%
Tumor Cell
13%
Gene Expression Profiling
13%
DNA Damage Response
13%
Messenger RNA
13%
Association
13%
Breast
12%
Consensus
12%
Overall Survival
11%
Gene Expression
10%
Ulcerative Colitis
10%
Glioblastoma
10%
Radiation Therapy
10%
Personalized Medicine
10%
Analysis
9%
Transcriptomics
8%
Biochemistry, Genetics and Molecular Biology
BRCA1
64%
Nested Gene
50%
Sample
44%
Development
37%
DNA Damage
33%
DNA Damage Response
33%
Cancer Cell
30%
Classification
23%
DNA
22%
Protein
21%
Kinase
20%
Mutation
16%
Immune Response
16%
Biomarker Discovery
16%
Mutant
15%
Phenotype
15%
Growth
14%
P53
14%
Small Interfering RNA
14%
Survival
13%
Microarray
13%
Radiation
13%
Gene Expression Profiling
12%
Apoptosis
12%
Gene Signature
12%
Messenger RNA
11%
Clinical Trial
11%
Ataxia Telangiectasia Mutated
11%
Consensus
11%
Homologous Recombination
10%
Gene Expression
10%
STAT3
10%
Phosphorylation
9%
Drug Resistance
9%
Comprehension
9%
Association
9%
Poly ADP Ribose Polymerase
8%
Drive
8%
Upregulation
8%
Oxidative Stress
8%
Transcriptomics
8%
Tyrosine Kinase
8%
Dynamics
8%
Microsatellite Instability
7%
Overall Survival
7%
Isoform
7%
Signal Transduction
7%
Adhesion
7%
Small Molecule
7%
Anthracycline
7%
Pharmacology, Toxicology and Pharmaceutical Science
DNA
56%
Biological Marker
44%
Breast Cancer
39%
Neoplasm
34%
Chemotherapy
31%
Malignant Neoplasm
25%
Prostate Cancer
21%
Formaldehyde
21%
Paraffin
21%
Recurrent Disease
18%
Ovary Cancer
16%
Colon Cancer
16%
Diseases
13%
Cisplatin
13%
Triple Negative Breast Cancer
11%
Esophageal Adenocarcinoma
10%
Drug Screening
10%
Solid Malignant Neoplasm
10%
Phosphotransferase
10%
RNA
8%
Apoptosis
8%
Anthracycline
7%
Small Interfering RNA
7%
Toxicity
6%
Saracatinib
6%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
6%
Leukemia
6%
Ataxia Telangiectasia
5%
Transcriptome
5%
Ovary Carcinoma
5%
Legumain
5%
Non Small Cell Lung Cancer
5%
Cystatin M
5%
Peptide
5%
Phosphotransferase Inhibitor
5%
Colorectal Cancer
5%
ATM Protein
5%
Immunotherapy
5%
Oxaliplatin
5%
Messenger RNA
5%
Angiogenesis Inhibitor
5%
Ionizing Radiation
5%
Prostate Tumor
5%
Metastasis Free Survival
5%
Adenocarcinoma
5%
Drug
5%
